Brain surgery delivers gene therapy to fight Parkinson's
NCT ID NCT07267065
Summary
This early-stage study is testing whether a gene therapy delivered directly to the brain is safe and might help people with young-onset Parkinson's disease. The therapy uses a modified virus to deliver a gene that helps brain cells produce more dopamine, the chemical that's low in Parkinson's. Nine participants will undergo brain surgery to receive the experimental treatment, and researchers will monitor them closely for safety and any changes in their symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ohio State University
Columbus, Ohio, 43210, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.